| 1.09 -0.21 (-16.15%) | 09-29 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.98 |
1-year : | 4.07 |
| Resists | First : | 2.55 |
Second : | 3.49 |
| Pivot price | 1.39 |
|||
| Supports | First : | 1.04 |
Second : | 0.87 |
| MAs | MA(5) : | 1.27 |
MA(20) : | 1.46 |
| MA(100) : | 2.55 |
MA(250) : | 3.82 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 7.1 |
D(3) : | 7.7 |
| RSI | RSI(14): 24.6 |
|||
| 52-week | High : | 6.96 | Low : | 1.04 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NMTC ] has closed below the lower bollinger band by 7.5%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ NMTC ] is to continue within current trading range. Bollinger Bands are 36.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.32 - 1.33 | 1.33 - 1.34 |
| Low: | 1.03 - 1.04 | 1.04 - 1.05 |
| Close: | 1.08 - 1.09 | 1.09 - 1.1 |
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.
Thu, 17 Sep 2026
Electric-shock facial pain gets a new treatment option in Southern California - Stock Titan
Wed, 09 Sep 2026
NMTC: Innovative thin film tech and key partnerships fuel growth in epilepsy and pain markets - TradingView
Tue, 08 Sep 2026
NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com
Tue, 08 Sep 2026
NeuroOne Medical (NMTC) exec buys shares and receives 35,000 options - Stock Titan
Thu, 25 Jun 2026
NMTC Forecast — Price Target — Prediction for 2027 - TradingView
Mon, 18 May 2026
Earnings call transcript: NeuroOne misses Q2 2026 forecasts, stock rises - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 9 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 25.2 (%) |
| Held by Institutions | 22.4 (%) |
| Shares Short | 82 (K) |
| Shares Short P.Month | 12 (K) |
| EPS | -0.98 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.43 |
| Profit Margin | -59.8 % |
| Operating Margin | -122.9 % |
| Return on Assets (ttm) | -58.1 % |
| Return on Equity (ttm) | -124.7 % |
| Qtrly Rev. Growth | 16.2 % |
| Gross Profit (p.s.) | 0.31 |
| Sales Per Share | 1.36 |
| EBITDA (p.s.) | -0.85 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -7 (M) |
| Levered Free Cash Flow | -5 (M) |
| PE Ratio | -1.13 |
| PEG Ratio | 0 |
| Price to Book value | 2.53 |
| Price to Sales | 0.79 |
| Price to Cash Flow | -1.41 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|